Since December, when the US Department of Justice began releasing large batches of documents relating to the financier and convicted sex offender Jeffrey Epstein, details have steadily been emerging about his extensive ties to prominent scientists and research institutions. The default response of most in academia has been to say very little, in the hope of avoiding scrutiny, unless a clear connection to Epstein emerges. But the fact that an individual with no scientific expertise who was convicted of child sex abuse in 2008 was able to ingratiate himself deeply with academics and influence research for years points to a serious cultural failing. It demands honest reflection, not avoidance.
Funding from individual donors: lessons from the Epstein case
One ethical challenge raised by the Epstein scandal is how to address the conduct of those who befriended him, sought funding from him or responded to his requests for favours. In tackling this, transparency, due process and, when warranted, exclusion from conferences or dismissal from academic positions will be essential. The deeper lesson is unmistakable: faculty members must never be left to manage patron relationships without institutional oversight.
There is nothing inherently wrong with cultivating relationships with potential donors. But many of Epstein’s associations that later proved problematic continued for much too long without supervisors, administrators or major-gift officers being informed. Researchers’ belated expressions of regret and claims of ‘nerd tunnel vision’ — that is, being too engrossed in research to notice warning signs — illustrate the hazards of allowing faculty members to manage donor relationships unchecked.
Similarly, institutions must consider whether buildings, fellowships and awards should continue to use the names of benefactors who had ties to Epstein. There is a clear precedent: numerous museums and universities have removed the Sackler family name from galleries and programmes because of the family’s leadership of Purdue Pharma, the company behind OxyContin, a drug widely blamed for fuelling the US opioid epidemic. Major institutions, including the Solomon R. Guggenheim Museum in New York City and the British Museum in London, have renamed spaces that once carried the Sackler name.
Scientists face fallout for past associations with Epstein
But there is one question that has received far too little attention: how could this mess have happened? Why did Epstein’s overtures to scientists — and their willingness to engage with him — so often fail to arouse institutions’ concern, let alone trigger outright rejection?
Around the world, many universities encourage individual faculty members to pursue private funding. However, academics are often naive when it comes to ensuring the appropriateness of donors, not least because the promotion system frequently rewards not caution, but the acquisition of major research funds.
